Similar articles for PMID: 25726554

Year	Number of Results
1993	1
1995	1
1997	2
1998	2
2000	1
2004	2
2005	3
2006	1
2007	1
2008	5
2009	6
2010	2
2011	5
2012	7
2013	7
2014	5
2015	10
2016	9
2017	8
2018	9
2019	4
2020	11
2021	8
2022	4
2023	6
2024	0

1

Long-term experience in the treatment of α1-antitrypsin deficiency: 25 years of augmentation therapy.

Teschler H. Teschler H. Eur Respir Rev. 2015 Mar;24(135):46-51. doi: 10.1183/09059180.10010714. Eur Respir Rev. 2015. PMID: 25726554 Free PMC article. Review.

2

Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.

Dummer J, Dobler CC, Holmes M, Chambers D, Yang IA, Parkin L, Smith S, Wark P, Dev A, Hodge S, Dabscheck E, Gooi J, Samuel S, Knowles S, Holland AE. Dummer J, et al. Respirology. 2020 Mar;25(3):321-335. doi: 10.1111/resp.13774. Epub 2020 Feb 6. Respirology. 2020. PMID: 32030868 Free PMC article. Review.

3

Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.

Edgar RG, Patel M, Bayliss S, Crossley D, Sapey E, Turner AM. Edgar RG, et al. Int J Chron Obstruct Pulmon Dis. 2017 May 2;12:1295-1308. doi: 10.2147/COPD.S130440. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28496314 Free PMC article. Review.

4

Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.

Blanco I, Lara B, de Serres F. Blanco I, et al. Orphanet J Rare Dis. 2011 Apr 12;6:14. doi: 10.1186/1750-1172-6-14. Orphanet J Rare Dis. 2011. PMID: 21486454 Free PMC article. Review.

5

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.

Rahaghi FF, Miravitlles M. Rahaghi FF, et al. Respir Res. 2017 May 30;18(1):105. doi: 10.1186/s12931-017-0574-1. Respir Res. 2017. PMID: 28558837 Free PMC article. Review.

6

Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.

O'Brien ME, Fee L, Browne N, Carroll TP, Meleady P, Henry M, McQuillan K, Murphy MP, Logan M, McCarthy C, McElvaney OJ, Reeves EP, McElvaney NG. O'Brien ME, et al. Thorax. 2020 Apr;75(4):321-330. doi: 10.1136/thoraxjnl-2019-214076. Epub 2020 Jan 20. Thorax. 2020. PMID: 31959730 Free PMC article.

7

Alpha1-antitrypsin deficiency: forgotten etiology.

Kaplan A, Cosentino L. Kaplan A, et al. Can Fam Physician. 2010 Jan;56(1):19-24. Can Fam Physician. 2010. PMID: 20090075 Free PMC article. Review.

8

SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.

Sorrells S, Camprubi S, Griffin R, Chen J, Ayguasanosa J. Sorrells S, et al. Respir Med. 2015 Apr;109(4):490-9. doi: 10.1016/j.rmed.2015.01.022. Epub 2015 Feb 13. Respir Med. 2015. PMID: 25727857 Free article. Clinical Trial.

9

Alpha-1 antitrypsin augmentation therapy.

Wewers MD, Crystal RG. Wewers MD, et al. COPD. 2013 Mar;10 Suppl 1:64-7. doi: 10.3109/15412555.2013.764402. COPD. 2013. PMID: 23527997 Review.

10

α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.

Campos MA, Lascano J. Campos MA, et al. Ther Adv Respir Dis. 2014 Oct;8(5):150-61. doi: 10.1177/1753465814542243. Epub 2014 Jul 9. Ther Adv Respir Dis. 2014. PMID: 25013223 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year